- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06357247
The Effect of SRS on Hemiplegia in Stroke Survivors
April 4, 2024 updated by: Virginia Commonwealth University
The Effect of SRS on Hemiplegia in Stroke Survivors: A Feasibility Study
Strokes are one of the leading causes of long term disability and death in the United States.
A stroke occurs when the blood supply to the brain is blocked, damaging parts of the brain.
Many stroke survivors have difficulty completing dexterous hand movements and manipulating objects due brain damage in the sensorimotor cortex.
Damage to these areas can cause decreased motor movements and tactile sensation on the affected side.
Research shows that tactile sensation is necessary for maintaining grip, grading grip forces and decreasing object slippage.
Therefore, it is important to address tactile sensation with motor performance during stroke rehabilitation to improve performance outcomes among stroke survivors.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
A novel intervention that has shown immediate improvements in tactile sensation is called stochastic resonance stimulation.
SRS is a phenomenon where cutaneous sensation can be enhanced with the presence of tactile noise in a nonlinear system.
This theory suggests that the application of an imperceptible vibrotactile stimulation increases the synchronization of afferent neurons firing to the somatosensory cortex, ultimately increasing the excitability of mechanoreceptors in the skin suggesting that afferent signals from the periphery to the somatosensory cortex influence motor movements.
However, more research is needed to document the changes in motor performance with the use of SRS and it is unclear how SRS stimulation changes different measurable sensory processing differences
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Virginia Chu
- Phone Number: (804) 828-1564
- Email: vchu@vcu.edu
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 232398
- Recruiting
- Virginia Commonwealth University
-
Contact:
- Virginia Chu
- Phone Number: 804-828-1564
- Email: vchu@vcu.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Stroke survivors over the age of 18
- At least six months post stroke
- Ability to provide verbal informed consent and written informed consent
- Score of at least 56 on the Fugl meyer assessment total motor scores
- Able to detect at least 6.65 (300 grams) on the Semmes Weinstein monofilament on both the pads of the thumb and index finger
- Able to complete the nine hole peg test
- Able to reliably express pain, discomfort, or fear
- Speak english
Exclusion Criteria:
- History of upper extremity orthopedic conditions, such as arthritis, surgery, etc.
- Aphasia caused by stroke
- Does not have AROM
- Currently have muscle contractures in upper extremity
- Participating in other research studies
- Patients with electrically operated implanted device (e.g. cardiac pacemaker/defibrillator, drug delivery pump, and neurostimulator)
- History of SMI (e.g. schizophrenia, schizoaffective disorder)
- History of neurodegenerative disability (e.g. Multiple Sclerosis, Parkinson's Disease)
- Have received botulinum injections in the paretic limb within the past three months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Feasibility Arm
Wearing a stochastic resonance device at home in chronic stroke patients (six months or more post stroke).
|
Using a light, vibrotactile noise device on the participant's affected wrist.
The actuator will be positioned on both the dorsal and volar sides of the wrist.
Each participant's sensory threshold will be measured using the method of ascending and descending limits
The Nine-Hole Peg Test (NHPT) is considered as a gold standard measure of manual dexterity and most frequently used in MS research and clinical practice.
The score for the 9-HPT is an average of the four trials.
The two trials for each hand are averaged, converted to the reciprocals of the mean times for each hand and then the two reciprocals are averaged.
On average, healthy male adults complete the NHPT in 19.0 seconds (SD 3.2) with the right hand, and in 20.6 seconds (SD 3.9) with the left hand.
A non-invasive, low-cost, simple, and accurate handheld calibrated nylon thread that buckles once it has delivered a force of 10 g.
It provides a standardized measure of a patient's ability to sense a point of pressure.
The filaments are classified from grade 1 to 5 according to their thickness: 1.65-2.83
= grade 5, 3.22-3.61
= grade 4, 3.84-4.31
= grade 3, 4.56-6.45
= grade 2, and 6.65 = grade 1.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Scores on ease of use, duration of wear, and preference related to wearing a stochastic resonance device at home in chronic stroke patients
Time Frame: Six months post stroke
|
To determine the feasibility of wearing a stochastic resonance device at home in chronic stroke patients.
This is administered through a participant questionnaire.
Some questions are point based (scale of 1-5), and some are open question answers.
|
Six months post stroke
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Optimal level of stochastic resonance vibration
Time Frame: Six months post stroke
|
To determine the optimal level of stochastic resonance vibration (120% vs 90% vs 60% of detection threshold) in stroke survivors
|
Six months post stroke
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Virginia Chu, Virginia Commonwealth University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 4, 2024
Primary Completion (Estimated)
August 1, 2024
Study Completion (Estimated)
August 1, 2024
Study Registration Dates
First Submitted
March 13, 2024
First Submitted That Met QC Criteria
April 4, 2024
First Posted (Actual)
April 10, 2024
Study Record Updates
Last Update Posted (Actual)
April 10, 2024
Last Update Submitted That Met QC Criteria
April 4, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HM20027093
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on Sensory Threshold
-
University of AarhusCompleted
-
University Hospital, MontpellierTerminatedPrimary Disease Facioscapulohumeral Dystrophy (FSHD)France
-
Universidade Federal de PernambucoCompleted
-
IRCCS San RaffaeleCompleted
-
Ospedali Riuniti TriesteCompleted
-
University of ValenciaCompletedRotator Cuff TendinitisSpain
-
Guangzhou Institute of Respiratory DiseaseCompletedChronic Obstructive Pulmonary DiseaseChina
-
Universidade Federal do Rio Grande do NorteFoundation for research support from the state of Rio Grande do Norte (FAPERN)Completed
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingChronic Pain | Chronic PancreatitisUnited States
-
Biruni UniversityThe Scientific and Technological Research Council of TurkeyRecruiting